Apis Capital Advisors’s Fibrocell Science FCSC Stock Holding History
Bought
Maintained
Sold
Other funds holding FCSC
Apis Capital Advisors's FCSC Position: Q2 2019 in Review
Apis Capital Advisors sold out of Fibrocell Science (FCSC) in Q2 2019, closing a stake of 25,000 shares — an estimated $48K sold.
Apis Capital Advisors first reported a position in FCSC in Q1 2019 and held it in 1 quarter. The position peaked at $48K in Q1 2019. 20 funds tracked by Wall St. Rank hold FCSC as of Q2 2019.
- Apis Capital Advisors reported no remaining Fibrocell Science position as of Q2 2019 after selling out during the quarter.
- Apis Capital Advisors sold 25,000 Fibrocell Science shares in Q2 2019, an estimated $48K.
- Apis Capital Advisors first reported a position in Fibrocell Science in Q1 2019 and held it in 1 quarter.
- Apis Capital Advisors's Fibrocell Science position peaked at $48K in Q1 2019.
- 20 funds tracked by Wall St. Rank held Fibrocell Science as of Q2 2019.
Based on Apis Capital Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.